Previous studies have reported that methamphetamine has been investigated and could promote the formation of amyloid‐β42, one of the key Alzheimer’s disease‐like pathological proteins,20 increase the expression of the tau protein,21 and produce greater dementia‐related oxidative stress markers including catalase and methane dicarboxylic aldehyde.22 The gene discussed is MAPT; the disease is dementia.